Skip NavigationSkip to Content
Return Return to Search Results

TLR-based immune adjuvants

  1. Author:
    Steinhagen, F.
    Kinjo, T.
    Bode, C.
    Klinman, D. M.

  2. Author Address

    [Steinhagen, F; Kinjo, T; Bode, C; Klinman, DM] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA;Klinman, DM (reprint author), NCI, Canc & Inflammat Program, Bldg 567,Rm 205, Frederick, MD 21702 USA;klinmand@mail.nih.gov
    1. Year: 2011
    2. Date: Apr
  2. Journal: Vaccine
    1. 29
    2. 17
    3. Pages: 3341-3355
  4. Type of Article: Review
  5. ISSN: 0264-410X
  1. Abstract:

    This work describes the nature and strength of the immune response induced by various Toll-like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various ligands capable of triggering individual TLRs, and then focuses on the efficacy and safety of those agents for which clinical results are available. Published by Elsevier Ltd.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.vaccine.2010.08.002
  3. View record in Web of Science®
  4. WOS: 000290603100037

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel